Sign in
4

Changes in Ownership

MAXCYTE, INC. Filed Acc 0001209191-23-020298

Options or other derivatives

  • Chief Financial Officer acquired 120,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Holtz Ron · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-03-20 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +120,000 120,000 D
Loading xslF345X04/doc4.xml…